Northwestern University: Prostatic Neoplasms trials

The registry lists 22 Prostatic Neoplasms studies with Northwestern University as lead sponsor. 3 are open to participants now and 4 have results posted.

Early Phase 1 2Phase 2 8Phase 3 1Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareRecruitingNCT06630962Not applicable
• FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY TrialRecruitingNCT06244004Phase 2
• rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active SurveillanceRecruitingNCT05852041Early Phase 1
• sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate CancerStatus unknownNCT04033432Phase 2Results posted
• (SGB) in Men Treated for Prostate Cancer Improve Hot FlashesTerminatedNCT03796195Phase 4Results posted
• Genistein in Treating Patients With Prostate CancerTerminatedNCT01126879Phase 2Results posted
• Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen DeprivationTerminatedNCT00058188Phase 3Results posted
• Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS)WithdrawnNCT06804785
• Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + AbirateroneWithdrawnNCT06060587Phase 2
• MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)Active, not recruitingNCT05424783
• PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate CancerWithdrawnNCT04910425Phase 2
• Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the ProstateCompletedNCT03853902Not applicable
• Mind-Body Health in Uro-Oncology: Research StudyCompletedNCT03852030Not applicable
• Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate CancerCompletedNCT03852017Not applicable
• The "PC-LIGHT" StudyCompletedNCT03419585Not applicable
• PET/MRI for the Staging of Newly Diagnosed Prostate CancerActive, not recruitingNCT03392181Early Phase 1
• Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate CancerCompletedNCT03149185Not applicable
• Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerActive, not recruitingNCT03016741Phase 4
• Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsActive, not recruitingNCT03012321Phase 2
• Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness EducationCompletedNCT02871752Not applicable
• Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate CancerWithdrawnNCT01087580Phase 2
• Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical ProstatectomyTerminatedNCT00058266Phase 2